Lidocain-Human Teva

Lidocaine, the active ingredient in Lidocain-Human Teva, is a local anesthetic presented as a sterile solution for intra‑articular, peri‑articular and intravenous use. It provides rapid onset of analgesia by blocking nerve conduction in targeted tissues. GNH USA supplies Lidocain-Human Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocain-Human Teva is a local anesthetic used in musculoskeletal and cardiovascular procedures. - Intra‑articular procedures: provides local anesthesia to facilitate joint surgery or diagnostic arthroscopy. - Peri‑articular infiltration: reduces postoperative pain after orthopedic surgery. - Intravenous administration: offers rapid analgesia and can be employed in anti‑arrhythmic therapy.

Lidocain-Human Teva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or tingling at the injection site - Mild dizziness or light‑headedness - Nausea or metallic taste - Transient hypotension - Localized swelling or erythema

Serious or Rare Side Effects: - Systemic toxicity presenting as seizures, cardiac arrhythmias, or respiratory depression - Allergic reactions including urticaria, angioedema, or anaphylaxis - Methemoglobinemia, especially with high cumulative doses - Persistent neurologic deficits (rare) - Severe hypotension or cardiovascular collapse

Before using Lidocain-Human Teva, clinicians should consider several safety measures. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular monitoring: observe for signs of toxicity, especially with high or rapid doses. - Hepatic impairment: adjust dose or monitor plasma levels due to reduced metabolism. - Concomitant CNS depressants: use with caution to avoid additive sedation. - Elderly patients: consider reduced clearance and lower dosing. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocain-Human Teva can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase lidocaine plasma concentrations. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic exposure. - Co‑administration with other local anesthetics: additive risk of systemic toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate cardiac depressant effects. - Diuretics: can alter plasma protein binding and increase free lidocaine. - General anesthetics (e.g., propofol, volatile agents): synergistic CNS depression may occur.